CVS Health
Prix: 101.96Entreprise et modèle économique
CVS Health operates as a diversified healthcare company, providing a range of services including pharmacy benefit management, retail pharmacy, and health insurance. Its core products encompass prescription medications, health services, and various health plans. Major business segments include Retail/LTC, Health Care Benefits, and Pharmacy Services, with primary revenue sources stemming from pharmacy sales, health insurance premiums, and service fees.
Profil d’investissement
The investment profile of CVS Health is more aligned with balanced investors, given its combination of growth potential and dividend yield. The company offers a moderate dividend, appealing to income-focused investors, while also showing potential for capital appreciation. The stock may suit those looking for a stable investment with a mix of growth and income.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 2.31 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- -5.0% ↓
- Surprise BPA
- 17.9% meilleur que prévu
- Volatilité 20 j
- 1.6% stable
- Rendement du dividende
- 2.6% modéré dernière date ex-dividende: 2026-04-23
Impact de la prévision
positifSuivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-05 02:35 | Conserver | Acheter | Positive momentum, but revenue decline raises concerns. |
| 2026-05-20 02:40 | Acheter | Conserver | Mixed performance; cautious outlook amid fundamental weakness. |
| 2026-05-08 15:02 | — | Acheter | Strong momentum and solid dividend yield support growth. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-06-08 11:26 | Mizuho Securities | Objectif relevé | 110 → 115 | 95.93 |
| 2026-06-04 11:50 | Morgan Stanley | Objectif relevé | 106 → 111 | 91.37 |
| 2026-06-01 11:26 | Truist Financial | Objectif relevé | 102 → 108 | 90.98 |